Home/Filings/4/0001178913-19-001086
4//SEC Filing

Aberman Zami 4

Accession 0001178913-19-001086

CIK 0001158780other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 4:17 PM ET

Size

8.2 KB

Accession

0001178913-19-001086

Insider Transaction Report

Form 4
Period: 2019-04-08
Aberman Zami
DirectorCEO & Co. Chairman
Transactions
  • Purchase

    Common Stock

    2019-04-08$0.70/sh+71,429$50,0004,939,727 total
  • Purchase

    Common Stock Warrant

    2019-04-08+71,42971,429 total
    Exercise: $0.70From: 2019-04-08Exp: 2024-04-08Common Stock (71,429 underlying)
Holdings
  • Common Stock

    (indirect: By Rose Hitech Ltd.)
    111,400
Footnotes (2)
  • [F1]The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.
  • [F2]The common stock warrants were exercisable immediately upon their issuance.

Issuer

PLURISTEM THERAPEUTICS INC

CIK 0001158780

Entity typeother

Related Parties

1
  • filerCIK 0001344740

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:17 PM ET
Size
8.2 KB